Characterizing vancomycin-resistant Enterococcus strains with various mechanisms of daptomycin resistance developed in an in vitro pharmacokinetic/pharmacodynamic model.
about
Daptomycin-nonsusceptible vancomycin-intermediate staphylococcus aureus vertebral osteomyelitis cases complicated by bacteremia treated with high-dose daptomycin and trimethoprim-sulfamethoxazoleMechanisms of drug resistance: daptomycin resistanceA current perspective on daptomycin for the clinical microbiologist.Daptomycin Pharmacokinetics and Pharmacodynamics in Septic and Critically Ill Patients.In Vitro Activities of Novel Antimicrobial Combinations against Extensively Drug-Resistant Acinetobacter baumannii.Comparative Pharmacodynamics of Single-Dose Oritavancin and Daily High-Dose Daptomycin Regimens against Vancomycin-resistant Enterococcus faecium Isolates in an In Vitro PK/PD Model of Infection.Solid-phase synthesis of fusaricidin/LI-F class of cyclic lipopeptides: Guanidinylation of resin-bound peptidyl amines.Evaluation of standard- and high-dose daptomycin versus linezolid against vancomycin-resistant Enterococcus isolates in an in vitro pharmacokinetic/pharmacodynamic model with simulated endocardial vegetations.Evaluation of Oritavancin Dosing Strategies against Vancomycin-Resistant Enterococcus faecium Isolates with or without Reduced Susceptibility to Daptomycin in an In Vitro Pharmacokinetic/Pharmacodynamic Model.
P2860
Q24620644-3141FFB5-22C1-4B53-99ED-A245668D59CCQ26779944-15B04D8D-7739-4F1E-9684-E6AB816FEA54Q37263289-46ADD1DA-8193-4F97-990F-162BFD720433Q38895642-9B0C0434-1749-4DB6-835A-A61BC0D8642EQ38964046-820AB90A-CF30-442B-A558-57F5148F921CQ40103272-F3A895F2-7E56-45EF-8B9D-A10F3952426DQ41893358-0CD48907-9F41-482C-9188-B644B24D4EB0Q42189998-1B40805E-AA7A-4495-BB90-B7AEC248DCD8Q48357083-79DD758E-238A-4391-BE6F-F5CC68E5C5D7
P2860
Characterizing vancomycin-resistant Enterococcus strains with various mechanisms of daptomycin resistance developed in an in vitro pharmacokinetic/pharmacodynamic model.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Characterizing vancomycin-resi ...... kinetic/pharmacodynamic model.
@en
type
label
Characterizing vancomycin-resi ...... kinetic/pharmacodynamic model.
@en
prefLabel
Characterizing vancomycin-resi ...... kinetic/pharmacodynamic model.
@en
P2093
P2860
P356
P1476
Characterizing vancomycin-resi ...... kinetic/pharmacodynamic model.
@en
P2093
Celine Vidaillac
Glenn W Kaatz
Michael J Rybak
Molly E Steed
Patricia Winterfield
Warren E Rose
P2860
P304
P356
10.1128/AAC.00084-11
P407
P577
2011-07-25T00:00:00Z